Conmed Corp (CNMD) Stock AnalysisCNMDStock AnalysisConmed Corp

CONMED Corporation is a medical technology company which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product line consists of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Conmed Corp is not a strong buy right now, as the current price is $49.98, which is close to the average analyst price target of $45. The RSI is at 43.84, indicating a neutral momentum, and the forward P/E ratio is 27.17, suggesting the stock may be overvalued compared to its earnings growth potential. The main risk is the recent downgrade from BofA, which has a target of $40, indicating potential downside.

6 analysts cover CNMD: 2 rate it Buy, 4 Hold and 0 Sell. The average price target is 50.00.